Clinical trials
Phase 3 Endometrial Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 10 |
| Active, not recruiting | 8 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| Gynecologic Oncology Group | 4 |
| AstraZeneca | 3 |
| National Cancer Institute (NCI) | 3 |
| Karyopharm Therapeutics Inc | 2 |
| Radiation Therapy Oncology Group | 2 |
| AEterna Zentaris | 1 |
| Advenchen Laboratories, LLC | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| BioNTech SE | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 39 |
| Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Fallopian Tube Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Uterine Neoplasms | 4 |
| Carcinoma, Ovarian Epithelial | 3 |
| Breast Carcinoma In Situ | 2 |
| Breast Neoplasms, Male | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.